Clinical Neuroscience Solutions, LLC

The trials here

What the 6 trials at this site are about, from their registry records.

Conditions

• Depression4 trials
• Bipolar disorder2 trials
• Atopic dermatitis (eczema)1 trial
• Obesity1 trial
• Type 2 diabetes1 trial

Phase

• Phase 36 trials

Status

• Active, not recruiting4 trials
• Recruiting2 trials

Lead sponsor

• Xenon Pharmaceuticals Inc.4 trials
• Amgen1 trial
• Pfizer1 trial

Running trials

• Recruiting

  Home Self-administration of Maridebart Cafraglutide With Autoinjector in Adults Living With Obesity or Overweight

  NCT07871409· Phase 3· Amgen· Source

• Recruiting

  A Study to Learn About the Study Medicine Called Tilrekimig in People With Moderate-to Severe Eczema

  NCT07783425· Phase 3· Pfizer· Source

• Active, not recruiting

  An Open-label Study of Azetukalner in Bipolar I or II Depression (X-CEED-OLE)

  NCT07217860· Phase 3· Xenon Pharmaceuticals Inc.· Source

• Active, not recruiting

  A Randomized Study of Azetukalner Versus Placebo in Depressive Episodes Associated With Bipolar I or II Disorder (Bipolar Depression)

  NCT07172516· Phase 3· Xenon Pharmaceuticals Inc.· Source

• Active, not recruiting

  An Open-Label Study of Azetukalner in Major Depressive Disorder

  NCT06922110· Phase 3· Xenon Pharmaceuticals Inc.· Source

• Active, not recruiting

  A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder

  NCT06775379· Phase 3· Xenon Pharmaceuticals Inc.· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Atopic dermatitis (eczema)1 recruiting
• Obesity1 recruiting
• Type 2 diabetes1 recruiting